01.02.2017 • NewsElaine Burridgeformaldehyderesins

Avalon and Bern University Research Formaldehyde Alternative

(c) Christina Richards/Shutterstock
(c) Christina Richards/Shutterstock

Switzerland’s Avalon Industries and the Institute for Materials and Wood Technology at the Bern University of Applied Sciences are collaborating on a research project to develop an environmentally friendly alternative to formaldehyde, a key material in adhesive resins for wood-based products.

In June 2014, the EU reclassified formaldehyde as carcinogenic and mutagenic. The project, which is government-sponsored by the Swiss Commission for Technology and Innovation, will look at replacing formaldehyde in phenol-formaldehyde (PF) resins with 5-hydroxymethylfurfural  (5-HMF), a bio-based, non-toxic chemical platform chemical.

Avalon said the project will build on the positive results from similar research run by parent company AVA-CO2 to develop non-toxic urea-HMF resins.

Thomas Kläusli, chief marketing officer at Avalon Industries, said the aim is to develop a formaldehyde-free, sustainable phenol-HMF adhesive for industrial use in the wood-processing industry. “We consider 5-HMF to be the most promising formaldehyde alternative for future resin production,” he said.

The EU produces about 10 million t/y of formaldehyde, with around 47 million t/y produced worldwide, according to Avalon. A large proportion of synthesized formaldehyde is used in the production of glues and impregnating resins for wood-based materials. Adhesive resins are used in the manufacture of particle boards, plywood panels and chipboards, with the furniture industry as one of the main users.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.